Cargando…
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare T-cell non-Hodgkin lymphoma characterized as CD30 positive and anaplastic lymphoma kinase (ALK) negative. In 2016, the World Health Organization declared BIA-ALCL as a new disease entity. The first case of BIA-ALCL was rep...
Autor principal: | Lee, Jun-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yeungnam University College of Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225493/ https://www.ncbi.nlm.nih.gov/pubmed/33461261 http://dx.doi.org/10.12701/yujm.2020.00801 |
Ejemplares similares
-
What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?
por: Lajevardi, Sepehr S., et al.
Publicado: (2022) -
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
por: Deva, Anand K., et al.
Publicado: (2020) -
A Systematic Review of Outcomes Following Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
por: Sharma, Kavita, et al.
Publicado: (2022) -
The State of the Art about Etiopathogenetic Models on Breast Implant Associated–Anaplastic Large Cell Lymphoma (BIA-ALCL): A Narrative Review
por: Cuomo, Roberto
Publicado: (2021) -
Abstract: Epidemiology and Risk Factors for Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in Australia & New Zealand
por: Knight, Robert, et al.
Publicado: (2016)